Dr. Hudson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
7339 El Cajon Blvd
San Diego, CA 92130
Education & Training
University of Southern California/Los Angeles General Medical Center (USC/LA General)Residency, Ophthalmology, 1992 - 1995
UCLA David Geffen School of Medicine/UCLA Medical CenterInternship, Internal Medicine, 1991 - 1992
Keck School of Medicine of the University of Southern CaliforniaClass of 1991
Certifications & Licensure
CA State Medical License 1993 - 2026
NM State Medical License 2014 - 2024
AZ State Medical License 1996 - 2022- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2013
- Fellow (FACS) American College of Surgeons
Clinical Trials
- A Randomized, Multi-center, Phase II Study of the Safety, Tolerability and Bioactivity of Repeated Intravitreal Injections of iCo-007 as Monotherapy or in Combination With Ranibizumab or Laser Photocoagulation in the Treatment of Diabetic Macular Edema (the iDEAL Study) Start of enrollment: 2012 Feb 01
Publications & Presentations
PubMed
- 7 citationsCombination verteporfin photodynamic therapy ranibizumab-dexamethasone in choroidal neovascularization due to age-related macular degeneration: results of a phase II r...Ron P. Gallemore, Josh Wallsh, Henry L Hudson, Allen C. Ho, Richard Chace
Clinical Ophthalmology. 2017-01-24 - 18 citationsEvaluation of Very High- and Very Low-Dose Intravitreal Aflibercept in Patients with Neovascular Age-Related Macular DegenerationQuan Dong Nguyen, Peter A. Campochiaro, Syed Mahmood Shah, David J. Browning, Henry L. Hudson
Journal of Ocular Pharmacology and Therapeutics. 2012-11-20 - 73 citationsA phase I study of intravitreal vascular endothelial growth factor trap-eye in patients with neovascular age-related macular degeneration.Quan Dong Nguyen, Syed Mahmood Shah, David J. Browning, Henry L. Hudson, Peter L. Sonkin
Ophthalmology. 2009-11-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
